EP3663285 - FORMYLPYRIDINE DERIVATIVE HAVING FGFR4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 22.12.2023 Database last updated on 08.10.2024 | |
Former | Grant of patent is intended Status updated on 16.08.2023 | ||
Former | Examination is in progress Status updated on 23.09.2022 | ||
Former | Request for examination was made Status updated on 08.05.2020 | ||
Former | The international publication has been made Status updated on 09.02.2019 | Most recent event Tooltip | 02.08.2024 | Lapse of the patent in a contracting state New state(s): PL | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Abbisko Therapeutics Co., Ltd. Room 721, No. 780 Cailun Road China (Shanghai) Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | [2023/41] |
Former [2020/24] | For all designated states Abbisko Therapeutics Co., Ltd. Room 721 No. 780 Cailun Road China (Shanghai) Pilot Free Zone Pudong New Area Shanghai 201203 / CN | Inventor(s) | 01 /
DENG, Haibing No.3, Lane 898 HaLei Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | 02 /
YANG, Fei No.3, Lane 898 HaLei Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | 03 /
YU, Hongping No.3, Lane 898 HaLei Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | 04 /
CHEN, Zhui No.3, Lane 898 HaLei Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | 05 /
XU, Yaochang No.3, Lane 898 HaLei Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | [2020/28] |
Former [2020/24] | 01 /
DENG, Haibing Room 721 No. 780 Cailun Road China (Shanghai)Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | ||
02 /
YANG, Fei Room 721 No. 780 Cailun Road China (Shanghai) Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | |||
03 /
YU, Hongping Room 721 No. 780 Cailun Road China (Shanghai) Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | |||
04 /
CHEN, Zhui Room 721 No. 780 Cailun Road China (Shanghai) Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | |||
05 /
XU, Yaochang Room 721 No. 780 Cailun Road China (Shanghai) Pilot Free Trade Zone Pudong New Area Shanghai 201203 / CN | Representative(s) | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [2020/24] | Application number, filing date | 18842293.5 | 01.08.2018 | [2020/24] | WO2018CN98078 | Priority number, date | CN201710661244 | 04.08.2017 Original published format: CN201710661244 | [2020/24] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019024876 | Date: | 07.02.2019 | Language: | ZH | [2019/06] | Type: | A1 Application with search report | No.: | EP3663285 | Date: | 10.06.2020 | Language: | EN | [2020/24] | Type: | B1 Patent specification | No.: | EP3663285 | Date: | 24.01.2024 | Language: | EN | [2024/04] | Search report(s) | International search report - published on: | CN | 07.02.2019 | (Supplementary) European search report - dispatched on: | EP | 08.04.2021 | Classification | IPC: | C07D401/14, A61P35/00 | [2021/14] | CPC: |
A61P35/00 (EP,US);
C07D401/14 (EP,US);
A61K31/444 (EP);
A61K31/506 (EP);
C07D213/04 (EP);
C07D213/75 (EP);
C07D401/12 (EP);
C07D405/14 (US);
C07D413/14 (US);
C07D491/107 (US)
(-)
|
Former IPC [2020/24] | C07D213/75, C07D213/04, C07D401/14, C07D401/12, A61K31/444, A61K31/506, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/24] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | FORMYLPYRIDINDERIVAT MIT FGFR4-HEMMENDER WIRKUNG, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON | [2020/24] | English: | FORMYLPYRIDINE DERIVATIVE HAVING FGFR4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | [2020/24] | French: | DÉRIVÉ DE FORMYLPYRIDINE AYANT UNE ACTIVITÉ INHIBITRICE DE FGFR4, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION | [2020/24] | Entry into regional phase | 30.12.2019 | Translation filed | 30.12.2019 | National basic fee paid | 30.12.2019 | Search fee paid | 30.12.2019 | Designation fee(s) paid | 30.12.2019 | Examination fee paid | Examination procedure | 30.12.2019 | Examination requested [2020/24] | 05.11.2021 | Amendment by applicant (claims and/or description) | 27.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2023 | Reply to a communication from the examining division | 17.08.2023 | Communication of intention to grant the patent | 19.12.2023 | Fee for grant paid | 19.12.2023 | Fee for publishing/printing paid | 19.12.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 20.08.2020 | Renewal fee patent year 03 | 24.08.2021 | Renewal fee patent year 04 | 25.08.2022 | Renewal fee patent year 05 | 25.08.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HR | 24.01.2024 | PL | 24.01.2024 | NO | 24.04.2024 | RS | 24.04.2024 | GR | 25.04.2024 | IS | 24.05.2024 | [2024/36] |
Former [2024/34] | HR | 24.01.2024 | |
NO | 24.04.2024 | ||
RS | 24.04.2024 | ||
GR | 25.04.2024 | ||
IS | 24.05.2024 | ||
Former [2024/33] | NO | 24.04.2024 | |
IS | 24.05.2024 | ||
Former [2024/32] | IS | 24.05.2024 | Documents cited: | Search | [XI]WO2016151499 (NOVARTIS AG [CH], et al); | [XP]WO2018010514 (NANJING INNOCARE PHARMA TECH CO LTD [CN]) | International search | [X]WO2016151499 (NOVARTIS AG [CH], et al) |